1887

Abstract

Hantaviruses are zoonotic viruses that cause life-threatening diseases when transmitted to humans. Severe hantavirus infection is manifested by impairment of renal function, pulmonary oedema and capillary leakage. Both innate and adaptive immune responses contribute to the pathogenesis, but the underlying mechanisms are not fully understood. Here, we showed that galectin-3-binding protein (Gal-3BP) was upregulated as a result of hantavirus infection both and . Gal-3BP is a secreted glycoprotein found in human serum, and increased Gal-3BP levels have been reported in chronic viral infections and in several types of cancer. Our experiments showed that, whilst Vero E6 cells (an African green monkey kidney cell line) constitutively expressed and secreted Gal-3BP, this protein was detected in primary human cells only as a result of hantavirus infection. Analysis of Gal-3BP levels in serum samples of cynomolgus macaques infected experimentally with hantavirus indicated that hantavirus infection induced Gal-3BP also . Finally, analysis of plasma samples collected from patients hospitalized because of acute hantavirus infection showed higher Gal-3BP levels during the acute than the convalescent phase. Furthermore, the Gal-3BP levels in patients with haemorrhagic fever with renal syndrome correlated with increased complement activation and with clinical variables reflecting the severity of acute hantavirus infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.066837-0
2014-11-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/11/2356.html?itemId=/content/journal/jgv/10.1099/vir.0.066837-0&mimeType=html&fmt=ahah

References

  1. Artini M., Natoli C., Tinari N., Costanzo A., Marinelli R., Balsano C., Porcari P., Angelucci D., D’Egidio M.. & other authors ( 1996;). Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients. . J Hepatol 25:, 212–217. [CrossRef][PubMed]
    [Google Scholar]
  2. Björkström N. K., Lindgren T., Stoltz M., Fauriat C., Braun M., Evander M., Michaëlsson J., Malmberg K. J., Klingström J.. & other authors ( 2011;). Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. . J Exp Med 208:, 13–21. [CrossRef][PubMed]
    [Google Scholar]
  3. Borges A. A., Campos G. M., Moreli M. L., Souza R. L., Aquino V. H., Saggioro F. P., Figueiredo L. T.. ( 2006;). Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. . Microbes Infect 8:, 2324–2330. [CrossRef][PubMed]
    [Google Scholar]
  4. Darcissac E. C., Vidal V., De La Tribonniere X., Mouton Y., Bahr G. M.. ( 2001;). Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy. . Clin Exp Immunol 126:, 287–294. [CrossRef][PubMed]
    [Google Scholar]
  5. Denard J., Beley C., Kotin R., Lai-Kuen R., Blot S., Leh H., Asokan A., Samulski R. J., Moullier P.. & other authors ( 2012;). Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6. . J Virol 86:, 6620–6631. [CrossRef][PubMed]
    [Google Scholar]
  6. Gavrilovskaya I., Gorbunova E., Koster F., Mackow E.. ( 2012;). Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. . Adv Virol 2012:, 674360.[PubMed]
    [Google Scholar]
  7. Geimonen E., Neff S., Raymond T., Kocer S. S., Gavrilovskaya I. N., Mackow E. R.. ( 2002;). Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. . Proc Natl Acad Sci U S A 99:, 13837–13842. [CrossRef][PubMed]
    [Google Scholar]
  8. Gorbunova E., Gavrilovskaya I. N., Mackow E. R.. ( 2010;). Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. . J Virol 84:, 7405–7411. [CrossRef][PubMed]
    [Google Scholar]
  9. Grassadonia A., Tinari N., Iurisci I., Piccolo E., Cumashi A., Innominato P., D’Egidio M., Natoli C., Piantelli M., Iacobelli S.. ( 2002;). 90K (Mac-2 BP) and galectins in tumor progression and metastasis. . Glycoconj J 19:, 551–556. [CrossRef][PubMed]
    [Google Scholar]
  10. Gröschel B., Braner J. J., Funk M., Linde R., Doerr H. W., Cinatl J. Jr, Iacobelli S.. ( 2000;). Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. . J Clin Immunol 20:, 117–122. [CrossRef][PubMed]
    [Google Scholar]
  11. Hepojoki J., Strandin T., Vaheri A., Lankinen H.. ( 2010a;). Interactions and oligomerization of hantavirus glycoproteins. . J Virol 84:, 227–242. [CrossRef][PubMed]
    [Google Scholar]
  12. Hepojoki J., Strandin T., Wang H., Vapalahti O., Vaheri A., Lankinen H.. ( 2010b;). Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. . J Gen Virol 91:, 2341–2350. [CrossRef][PubMed]
    [Google Scholar]
  13. Huiskonen J. T., Hepojoki J., Laurinmäki P., Vaheri A., Lankinen H., Butcher S. J., Grünewald K.. ( 2010;). Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. . J Virol 84:, 4889–4897. [CrossRef][PubMed]
    [Google Scholar]
  14. Ichikawa Y., Ishikawa T., Momiyama N., Kamiyama M., Sakurada H., Matsuyama R., Hasegawa S., Chishima T., Hamaguchi Y.. & other authors ( 2006;). Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of β-catenin in the nucleus of human umbilical vein endothelial cells. . Oncol Rep 15:, 311–315.[PubMed]
    [Google Scholar]
  15. Ii M., Yamamoto H., Adachi Y., Maruyama Y., Shinomura Y.. ( 2006;). Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. . Exp Biol Med (Maywood) 231:, 20–27.[PubMed]
    [Google Scholar]
  16. Jonsson C. B., Figueiredo L. T., Vapalahti O.. ( 2010;). A global perspective on hantavirus ecology, epidemiology, and disease. . Clin Microbiol Rev 23:, 412–441. [CrossRef][PubMed]
    [Google Scholar]
  17. Kittl E. M., Hofmann J., Hartmann G., Sebesta C., Beer F., Bauer K., Huber K. R.. ( 2000;). Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection. . Clin Chem Lab Med 38:, 205–208. [CrossRef][PubMed]
    [Google Scholar]
  18. Klempa B., Meisel H., Räth S., Bartel J., Ulrich R., Krüger D. H.. ( 2003;). Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. . J Clin Microbiol 41:, 4894–4897. [CrossRef][PubMed]
    [Google Scholar]
  19. Klingström J., Plyusnin A., Vaheri A., Lundkvist A.. ( 2002;). Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. . J Virol 76:, 444–449. [CrossRef][PubMed]
    [Google Scholar]
  20. Klingström J., Stoltz M., Hardestam J., Ahlm C., Lundkvist A.. ( 2008;). Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge. . Antivir Ther 13:, 125–133.[PubMed]
    [Google Scholar]
  21. Laferté S., Loh L. C., Keeler V.. ( 2000;). Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function. . J Cell Biochem 77:, 540–559. [CrossRef][PubMed]
    [Google Scholar]
  22. Li Y., Wang W., Wang J. P., Pan L., Zhang Y., Yu H. T., Jiang W., Wang P. Z., Bai X. F.. ( 2012;). Elevated vascular endothelial growth factor levels induce hyperpermeability of endothelial cells in hantavirus infection. . J Int Med Res 40:, 1812–1821. [CrossRef][PubMed]
    [Google Scholar]
  23. Livak K. J., Schmittgen T. D.. ( 2001;). Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. . Methods 25:, 402–408. [CrossRef][PubMed]
    [Google Scholar]
  24. Lodermeyer V., Suhr K., Schrott N., Kolbe C., Stürzel C. M., Krnavek D., Münch J., Dietz C., Waldmann T.. & other authors ( 2013;). 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1. . Retrovirology 10:, 111. [CrossRef][PubMed]
    [Google Scholar]
  25. Longo G., Natoli C., Rafanelli D., Tinari N., Morfini M., Rossi-Ferrini P., D’Ostilio N., Iacobelli S.. ( 1993;). Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients. . Br J Haematol 85:, 207–209. [CrossRef][PubMed]
    [Google Scholar]
  26. Mackow E. R., Gavrilovskaya I. N.. ( 2009;). Hantavirus regulation of endothelial cell functions. . Thromb Haemost 102:, 1030–1041.[PubMed]
    [Google Scholar]
  27. Mäkelä S., Mustonen J., Ala-Houhala I., Hurme M., Partanen J., Vapalahti O., Vaheri A., Pasternack A.. ( 2002;). Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(−308) G/A polymorphism. . J Infect Dis 186:, 843–846. [CrossRef][PubMed]
    [Google Scholar]
  28. Mustonen J., Partanen J., Kanerva M., Pietilä K., Vapalahti O., Pasternack A., Vaheri A.. ( 1996;). Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. . Kidney Int 49:, 217–221. [CrossRef][PubMed]
    [Google Scholar]
  29. Natoli C., Ortona L., Tamburrini E., Tinari N., Di Stefano P., D’Egidio M., Ghinelli F., Sighinolfi L., D’Ostilio N.. & other authors ( 1994;). Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV). . Anticancer Res 14: (3B), 1457–1460.[PubMed]
    [Google Scholar]
  30. Outinen T. K., Mäkelä S. M., Ala-Houhala I. O., Huhtala H. S., Hurme M., Paakkala A. S., Pörsti I. H., Syrjänen J. T., Mustonen J. T.. ( 2010;). The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. . BMC Infect Dis 10:, 132. [CrossRef][PubMed]
    [Google Scholar]
  31. Paakkala A., Mustonen J., Viander M., Huhtala H., Pasternack A.. ( 2000;). Complement activation in nephropathia epidemica caused by Puumala hantavirus. . Clin Nephrol 53:, 424–431.[PubMed]
    [Google Scholar]
  32. Park Y. P., Choi S. C., Kim B. Y., Kim J. T., Song E. Y., Kang S. H., Yoon D. Y., Paik S. G., Kim K. D.. & other authors ( 2008;). Induction of Mac-2BP by nerve growth factor is regulated by the PI3K/Akt/NF-κB-dependent pathway in the HEK293 cell line. . BMB Rep 41:, 784–789. [CrossRef][PubMed]
    [Google Scholar]
  33. Piccolo E., Tinari N., Semeraro D., Traini S., Fichera I., Cumashi A., La Sorda R., Spinella F., Bagnato A.. & other authors ( 2013;). LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. . J Mol Med (Berl) 91:, 83–94. [CrossRef][PubMed]
    [Google Scholar]
  34. Sane J., Laine O., Makela S., Paakkala A., Jarva H., Mustonen J., Vapalahti O., Meri S., Vaheri A.. ( 2011;). Complement activation in puumala hantavirus infection correlates with disease severity. . Ann Med 44:, 468–475. [CrossRef][PubMed]
    [Google Scholar]
  35. Shrivastava-Ranjan P., Rollin P. E., Spiropoulou C. F.. ( 2010;). Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. . J Virol 84:, 11227–11234. [CrossRef][PubMed]
    [Google Scholar]
  36. Sironen T., Klingström J., Vaheri A., Andersson L. C., Lundkvist A., Plyusnin A.. ( 2008;). Pathology of Puumala hantavirus infection in macaques. . PLoS ONE 3:, e3035. [CrossRef][PubMed]
    [Google Scholar]
  37. Thrailkill K. M., Clay Bunn R., Fowlkes J. L.. ( 2009;). Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. . Endocrine 35:, 1–10. [CrossRef][PubMed]
    [Google Scholar]
  38. Tuuminen T., Kekäläinen E., Mäkelä S., Ala-Houhala I., Ennis F. A., Hedman K., Mustonen J., Vaheri A., Arstila T. P.. ( 2007;). Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. . J Immunol 179:, 1988–1995. [CrossRef][PubMed]
    [Google Scholar]
  39. Ullrich A., Sures I., D’Egidio M., Jallal B., Powell T. J., Herbst R., Dreps A., Azam M., Rubinstein M.. & other authors ( 1994;). The secreted tumor-associated antigen 90K is a potent immune stimulator. . J Biol Chem 269:, 18401–18407.[PubMed]
    [Google Scholar]
  40. Ulmer T. A., Keeler V., André S., Gabius H. J., Loh L., Laferté S.. ( 2010;). The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: implications of proteolytic cleavage. . Biochim Biophys Acta 1800:, 336–343. [CrossRef][PubMed]
    [Google Scholar]
  41. Vaheri A., Mills J. N., Spiropoulou C. F., Hjelle B.. ( 2011;). Hantaviruses. . In Zoonoses: Biology, Clinical Practice and Public Health, , 2nd edn., pp. 307–322. Edited by Palmer S. R., Soulsby L., Brown D., Torgeson P... Oxford:: Oxford University Press;.
    [Google Scholar]
  42. Vaheri A., Strandin T., Hepojoki J., Sironen T., Henttonen H., Mäkelä S., Mustonen J.. ( 2013;). Uncovering the mysteries of hantavirus infections. . Nat Rev Microbiol 11:, 539–550. [CrossRef][PubMed]
    [Google Scholar]
  43. Vapalahti O., Kallio-Kokko H., Salonen E. M., Brummer-Korvenkontio M., Vaheri A.. ( 1992;). Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. . J Gen Virol 73:, 829–838. [CrossRef][PubMed]
    [Google Scholar]
  44. Vapalahti O., Lundkvist A., Kallio-Kokko H., Paukku K., Julkunen I., Lankinen H., Vaheri A.. ( 1996;). Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells. . J Clin Microbiol 34:, 119–125.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.066837-0
Loading
/content/journal/jgv/10.1099/vir.0.066837-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error